Skip to main content
. 2019 Dec 6;10:1434. doi: 10.3389/fphar.2019.01434

Figure 2.

Figure 2

Multistage mass spectra of doxorubicin and its metabolites. (AE) MS1∼MS5 mass fragmentation of doxorubicin, (FJ) MS1∼MS5 mass fragmentation of doxorubicin metabolites M1, (KO) MS1∼MS5 mass fragmentation of doxorubicin metabolites M2, (PT) MS1∼MS5 mass fragmentation of doxorubicin metabolites M3.